Cover Image

Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database

(1) Background: The purpose of study was to compare the safety profile of glatiramer with natalizumab, alemtuzumab and ocrelizumab in pregnant and lactating women affected by multiple sclerosis (MS). (2) Methods: Individual case safety reports (ICSRs) were retrieved from the European spontaneous rep...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liberata Sportiello (Author), Raffaella Di Napoli (Author), Nunzia Balzano (Author), Annamaria Mascolo (Author), Rosanna Ruggiero (Author), Luigi Di Costanzo (Author), Davida Monaco (Author), Giorgia Teresa Maniscalco (Author), Annalisa Capuano (Author)
Format:	Book
Published:	MDPI AG, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
by: Cristina Scavone, et al.
Published: (2022)

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database
by: Giuseppe Cicala, et al.
Published: (2024)

Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
by: Fabrizio Calapai, et al.
Published: (2024)

Safety profile of tirzepatide: A real-world pharmacovigilance analysis of EudraVigilance database
by: Atul Khurana, et al.
Published: (2024)

Evaluation of quantitative signal detection in EudraVigilance for orphan drugs: possible risk of false negatives
by: Marco Sardella, et al.
Published: (2019)

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007-2018
by: Iwona Popiołek, et al.
Published: (2019)

Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance
by: Gabriela Pop, et al.
Published: (2022)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
by: Annamaria Mascolo, et al.
Published: (2023)

Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
by: Fabrizio Calapai, et al.
Published: (2023)

Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution
by: Fabrizio Calapai, et al.
Published: (2023)

A Descriptive Analysis of Direct Oral Anticoagulant Drugs Dosing Errors Based on Spontaneous Reports from the EudraVigilance Database
by: Claudiu Morgovan, et al.
Published: (2023)

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database
by: Michael Magdy Fahmy Girgis, et al.
Published: (2024)

Drug-Drug Interactions of Selective Serotonin Reuptake Inhibitors: A Pharmacovigilance Study on Real-World Evidence from the EudraVigilance Database
by: Carmen Maximiliana Dobrea, et al.
Published: (2024)

Characteristics and completeness of spontaneous reports by reporter's role in Germany: An analysis of the EudraVigilance database using the example of opioid‐associated abuse, dependence, or withdrawal
by: Kathrin Jobski, et al.
Published: (2023)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
by: Cristina Scavone, et al.
Published: (2020)

Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility
by: Michele Gringeri, et al.
Published: (2021)

A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated <i>Clostridioides difficile</i> Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units
by: Bogdan Ioan Vintila, et al.
Published: (2023)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)
by: Stefania Chiappini, et al.
Published: (2022)

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System
by: Annamaria Mascolo, et al.
Published: (2019)

Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2024)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
by: Rosanna Ruggiero, et al.
Published: (2020)

Sex and gender differences and pharmacovigilance: a knot still to be untied
by: Liberata Sportiello, et al.
Published: (2024)

It is the time to change the paradigms of pregnant and breastfeeding women in clinical research!
by: Liberata Sportiello, et al.
Published: (2023)

Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
by: Maurizio Sessa, et al.
Published: (2018)

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
by: Maurizio Sessa, et al.
Published: (2017)

Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma<sup>®</sup>) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
by: Rosanna Ruggiero, et al.
Published: (2024)

Sodium-glucose cotransporter-2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
by: Annamaria Mascolo, et al.
Published: (2023)

Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System
by: Elena Mirabela Velișcu, et al.
Published: (2023)

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
by: Cristina Scavone, et al.
Published: (2019)

The Vigil of Medicine
by: Kiersten Kelly
Published: (2021)

Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature
by: Annamaria Mascolo, et al.
Published: (2023)

The Vigilance Committee of 1856
by: O'Meara, James, 1825-1903

Introducing Vigilant Audiences
Published: (2020)

Introducing Vigilant Audiences
Published: (2020)

De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: the initial Iranian experience
by: Sepideh Paybast, et al.
Published: (2025)

Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study
by: Maurizio Sessa, et al.
Published: (2018)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021)

The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
by: Maria Maddalena Marrapodi, et al.
Published: (2022)

Vigilance et transports Aspects fondamentaux, dégradation et prévention
Published: (1995)

The Vigil of Venus and Other Poems by "Q"
by: Quiller-Couch, Arthur, 1863-1944